The top 10 neighbors for Nature Biotechnology span five distinct subcategories — a breadth that signals a mass-market audience shape rather than a tight disciplinary niche.

The shape is broad, with scores running from 0.97 down to 0.90 across all ten neighbors, and no single entity pulling far ahead of the rest. Nature Medicine leads at 0.97, followed by Nature at 0.94 and Nature Communications at 0.94. These three are fellow publications in the Nature Publishing orbit — two Magazines and one Website — and their presence confirms that the core of the audience overlaps heavily with readers of peer scientific journals. Nature News & Comment (0.92) extends that cluster into News Publishers.

The more structurally interesting finding is what sits alongside those journals. Genentech (0.92) is the first non-publication in the set — a Healthcare brand — and it lands above WIRED Science (0.92) and Science Magazine (0.91). Quanta Magazine (0.91) and MIT Technology Review (0.90) pull the cluster toward science-adjacent technology media, while Nieman Reports (0.90) — a journalism-trade Magazine — is the most unexpected entry, sitting at the same score tier as the science titles.

Tallying the top 10: five Magazines, two Websites, one News Publisher, and one Healthcare brand. No other category appears in the top 10. The dominant subcategory is Magazines (five of ten), but the presence of a pharma/biotech brand and a journalism-trade title at comparable scores indicates the audience is not purely defined by scientific publishing consumption.

The broad shape here reflects an audience that reads across scientific, biomedical, and technology-adjacent media simultaneously — a profile wide enough to overlap with both research institutions and industry.